VTVT Stock Analysis: Buy, Sell, or Hold?
VTVT - vTv Therapeutics Inc. Class A Common Stock
$37.10
0.54 (1.48%)
▲
5d:
-6.17%
30d:
+10.06%
90d:
+4.29%
HOLD
LOW Confidence
Analysis Updated: Apr 13, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When VTVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VTVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VTVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VTVT is currently trading at $37.10, which is considered fair relative to its 30-day fair value range of $35.30 to $38.98.
Technical Outlook: Technically, VTVT is in a uptrend. Immediate support is located at $35.04, while resistance sits at $43.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $53.33 (+43.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VTVT is in a uptrend. Immediate support is located at $35.04, while resistance sits at $43.09.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $53.33 (+43.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$35.30 -
$38.98
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.8% below Wall St target ($53.33)
- CAUTION: Recommendation downgraded due to -6.2% 5-day decline
Fair Price Analysis
30-Day Fair Range
$35.30 -
$38.98
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$35.04
Resistance Level
$43.09
Current Trend
Uptrend
Technical data as of
Apr 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.97
Wall Street Target
$53.33
(+43.8%)
Share & Embed Analysis
Last updated: April 13, 2026 6:18 PM ET
Data refreshes hourly during market hours. Next update: 7:18 PM
Data refreshes hourly during market hours. Next update: 7:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VTVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$111 | 57 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$132 | 64 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 63 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 57 HOLD |
